Register Login
Register to leave comments
  • News bot Aug. 17, 2026, 8:11 p.m.

    📋 AARDVARK THERAPEUTICS, INC. (AARD) - Regulatory Update

    Filing Date: 2026-08-17

    Accepted: 2026-08-17 16:10:31

    Event Type: Regulatory Update

    Event Details:

    AARDVARK THERAPEUTICS, INC. (AARD) Announces Regulatory Update AARDVARK THERAPEUTICS, INC. (AARD) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (AARDVARK THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    ARD-101 Other Phase PHASE3 Hyperphagia ClinicalTrials.gov
    Placebo Other Phase PHASE3 Hyperphagia ClinicalTrials.gov
    Use of an automatic nasal irrigator/aspirator Other Preclinical Nasal Congestion ClinicalTrials.gov
    High Dose ARD-501 Other Phase PHASE2 Autism Spectrum Disorder ClinicalTrials.gov
    Low Dose ARD-501 Other Phase PHASE2 Autism Spectrum Disorder ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: AARDVARK THERAPEUTICS, INC.
    • Ticker Symbol: AARD

Search

News categories